Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Conn. High Court Snapshot: $13.2M Estate Tax Tops January No Photo Available

Aaron Keller

The state of Connecticut's attempt to collect $13.2 million in taxes from the estate of a healthcare executive and a hospital's potent... (more story)

High Court's Med Mal Ruling Won't Spark Rise In Suits No Photo Available

Y. Peter Kang

The U.S. Supreme Court's recent ruling that a Delaware medical malpractice statute can't be enforced in federal court won't cause a no... (more story)

Justices To Clarify What's Fair Game With 'Skinny Labels' No Photo Available

Ryan Davis

A new U.S. Supreme Court patent case that will require the justices to spell out what generic-drug makers can say when marketing drugs... (more story)